Author

Lorraine C. Webber

Observed names: L. Webber, Lorraine C Webber, Lorraine Webber

Observed institutions: AstraZeneca (United Kingdom), Tulane University, King's College London, Queen Charlotte's and Chelsea Hospital, Chelsea and Westminster Hospital, Chelsea Hospital, AstraZeneca (United States), Millendo Therapeutics (United States), Imperial College London

OpenAlex ID: A5085979218

Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial

2017 · Julia K Prague, Rachel E Roberts, et al. · The Lancet · 215

Neurokinin B Receptor Antagonism in Women With Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Trial

2016 · Jyothis T. George, Rahul Kakkar, et al. · The Journal of Clinical Endocrinology & Metabolism · 131

Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action

2018 · Julia K. Prague, Rachel E. Roberts, et al. · Menopause The Journal of The North American Menopause Society · 95

Does home-based exercise improve body mass index in patients with type 2 diabetes?

2008 · M.A. Krousel-Wood, L. Berger, et al. · Diabetes Research and Clinical Practice · 62

Population Pharmacokinetic and Pharmacodynamic Modeling of AZD4901 and Simulation to Support Dose Selection for the Phase 2a Study

2015 · Hongmei Xu, Jianguo Li, et al. · The Journal of Clinical Pharmacology · 7

Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial

2017 · Julia Prague, Rachel Roberts, et al. · Endocrine Abstracts · 4

Neurokinin 3 Receptor Antagonism Rapidly Improves Vasomotor Symptoms With Sustained Duration of Action

2019 · Julia K. Prague, Rachel E. Roberts, et al. · Obstetrical & Gynecological Survey · 2

Neurokinin 3 receptor antagonism is a highly effective, novel treatment for menopausal hot flushes with rapid onset: a phase 2, randomised, double-blind, placebo-controlled trial

2017 · Julia Prague, Rachel Roberts, et al. · Endocrine Abstracts · 1

Correction: Cost-effectiveness of bariatric surgery and non-surgical weight management programmes for adults with severe obesity: a decision analysis model (International Journal of Obesity, (2021), 10.1038/s41366-021-00849-8)

2021 · Dwayne Boyers, Lise Retat, et al. · International Journal of Obesity

From bench to bedside and beyond: a novel therapy to improve wound healing in type 2 diabetes

2019 · Ramzi Ajjan, Elizabeth Hensor, et al. · Endocrine Abstracts

Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: A phase 2, randomised, double-blind, placebo controlled trial

2017 · Julia Prague, Rachel Roberts, et al. · Maturitas

A novel pharmacological approach to target LH and testosterone hypersecretion in women with polycystic ovary syndrome: a randomised, double-blind, placebo-controlled multi-centre randomised clinical trial of the neurokinin B receptor antagonist AZD4901

2015 · Jyothis George, Rahul Kakkar, et al. · Endocrine Abstracts

Works count: 12

Citation count: 517

H-index: 5

I10-index: 4